Chlorzoxazone reduced the paracetamol-induced toxicity via competitive inhibition of CYP2E1-mediated metabolism
Tóm tắt
Drug metabolism is crucial to attaining the therapeutic index of any drug. The metabolism and elimination of the drugs are governed mainly by P-glycoprotein (P-gp) and Cytochrome P450 (CYP). Paracetamol is mostly used as analgesic and antipyretic agent. The metabolism of paracetamol is primarily via Glucuronidation and sulphation at therapeutic doses. About 5–10% of paracetamol is metabolized via CYP mediated pathway. Cytochrome P450 2E1 (CYP2E1) is primarily responsible for forming a toxic metabolite of paracetamol called N-acetyl-p-benzoquinoneimine (NAPQI). Even at therapeutic doses, long-term usage of paracetamol leads to the hepatic and nephrotoxicity because of NAPQI. Several in-vitro and in-vivo studies conducted by different research groups and reported that chlorzoxazone is a substrate and inhibitor of CYP2E1. However, the effect of chlorzoxazone on the paracetamol (CYP2E1 substrate) metabolism via the CYP2E1 has not yet been reported. This study investigated the effect of chlorzoxazone on the CYP2E1-mediated metabolism of Paracetamol and NAPQI formation in Wistar rats. For 15 days, animals were orally administered with Paracetamol (300 mg/kg) with and without Silymarin (100 mg/kg) (standard CYP2E1 inhibitor) and Chlorzoxazone (50 and 100 mg/kg). Analysis was performed using RP-HPLC on the 15th day to determine paracetamol and NAPQI concentration in the plasma. Paracetamol combination with chlorzoxazone (50 and 100 mg/kg) showed a dose-dependent increase in the AUC0–∞ and the peak plasma concentration (Cmax) of Paracetamol and a dose-dependent decrease of AUC0–∞ and Cmax of NAPQI compared to paracetamol control (p < 0.001). Chlorzoxazone significantly decreased the elevated liver and renal markers compared to paracetamol control. Simultaneously, Hepatic and nephrotic tissue studies showed that compared to the paracetamol control group, the combination of chlorzoxazone significantly ameliorated paracetamol-induced hepatotoxicity and nephrotoxicity. Finally, this study revealed that paracetamol in combination with chlorzoxazone led to a significant decrease in the plasma levels of NAPQI and enhanced absorption of paracetamol in rats via the inhibition of CYP2E1- mediated metabolism. In addition, chlorzoxazone significantly ameliorated paracetamol-induced hepatotoxicity and nephrotoxicity.
Từ khóa
Tài liệu tham khảo
Jóźwiak-Bebenista M, Nowak JZ (2014) Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm 71:11–23
Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF (2013) The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology 21:201–232
Heubi JE, Barbacci MB, Zimmerman HJ (1998) Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 132:22–27
Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT (2000) Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 67:275–282
Jing Y, Wu K, Liu J, Ai Q, Ge P, Dai J, Jiang R, Zhou D, Che Q, Wan J (2015) Aminotriazole alleviates acetaminophen poisoning via downregulating P450 2E1 and suppressing inflammation. PLoS ONE 10:e0122781
Tomishima Y, Ishitsuka Y, Matsunaga N, Nagatome M, Furusho H, Irikura M, Ohdo S, Irie T (2013) Ozagrel hydrochloride, a selective thromboxane A2 synthase inhibitor, alleviates liver injury induced by acetaminophen overdose in mice. BMC Gastroenterol 13:1–10
Ying W, Yan-Ling W, Li-Hua L, Ji-Xing N (2012) Protective effect of Ornithogalum saundersiae Ait (Liliaceae) against acetaminophen-induced acute liver injury via CYP2E1 and HIF-1α. Chin J Nat Med 10:177–184
Zhao X, Cong X, Zheng L, Xu L, Yin L, Peng J (2012) Dioscin, a natural steroid saponin, shows remarkable protective effect against acetaminophen-induced liver damage in vitro and in vivo. Toxicol Lett 214:69–80
Kumari A, Kakkar P (2012) Lupeol prevents acetaminophen-induced in vivo hepatotoxicity by altering the Bax/Bcl-2 and oxidative stress-mediated mitochondrial signaling cascade. Life Sci 90:561–570
Kwak MK, Kim SG, Kwak JY, Novak RF, Kim ND (1994) Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethylsulfide in rats. Biochem Pharmacol 47:531–539
Oliveira FA, Chaves MH, Almeida FR, Lima RC Jr, Silva RM, Maia JL, Brito GAA, Santos FA, Rao VS (2005) Protective effect of α-and β-amyrin, a triterpene mixture from Protium heptaphyllum (Aubl.) March. trunk wood resin, against acetaminophen-induced liver injury in mice. J Ethnopharmacol 98:103–108
Su GL, Gong KQ, Fan MH, Kelley WM, Hsieh J, Sun JM, Hemmila MR, Arbabi S, Remick DG, Wang SC (2005) Lipopolysaccharide-binding protein modulates acetaminophen-induced liver injury in mice. Hepatology 41:187–195
Bayan MF, Jaradat A, Alyami MH, Naser AY (2023) Smart Pellets for Controlled Delivery of 5-Fluorouracil. Molecules 28:306
Jang S, Kim H, Hwang K, Jekal S, Pae H, Choi B, Yun Y, Kwon T, Chung H, Kim Y (2003) Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol 25:585–594
Bayan MF, Marji SM, Salem MS, Begum MY, Chidambaram K, Chandrasekaran B (2022) Development of polymeric-based formulation as potential smart colonic drug delivery system. Polymers 14:3697
Janbaz K, Gilani A (2000) Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia 71:25–33
Thomsen MS, Loft S, Roberts DW, Poulsen HE (1995) Cytochrome P4502E1 inhibition by propylene glycol prevents acetaminophen (paracetamol) hepatotoxicity in mice without cytochrome P4501A2 inhibition. Pharmacol Toxicol 76:395–399
Qiu-Ju L, Bessems JG, Commandeur JN, Adams B, Vermeulen NP (1994) Mechanism of protection of ebselen against paracetamol-induced toxicity in rat hepatocytes. Biochem Pharmacol 48:1631–1640
Lin MC, Wang EJ, Patten C, Lee MJ, Xiao F, Reuhl KR, Yang CS (1996) Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice. J Biochem Toxicol 11:11–20
Hong SW, Lee HS, Jung KH, Lee H, Hong SS (2012) Protective effect of fucoidan against acetaminophen-induced liver injury. Arch Pharmacal Res 35:1099–1105
Fan YJ, Rong Y, Li PF, Dong WI, Zhang DY, Zhang L, Cui MJ (2013) Genistein protection against acetaminophen-induced liver injury via its potential impact on the activation of UDP-glucuronosyltransferase and antioxidant enzymes. Food Chem Toxicol 55:172–181
Khemawoot P, Nishino K, Ishizaki J, Yokogawa K, Miyamoto KI (2007) Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats. Eur J Pharmacol 574:71–76
Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, Berthou F (1999) Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics 9:377–388
Pingili R, Vemulapalli S, Mullapudi SS, Nuthakki S, Pendyala S, Kilaru N (2016) Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats. Drug Dev Ind Pharm 42:1110–1117
Sridhar V, Surya SM, Ravindra BP, Naveen BK (2014) Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using felodipine and hesperetin in combination in Wistar rats and everted rat gut sacs in vitro. Phytother Res 28:699–705
Surya SM, Sridhar V, Puneeth Y, Ravindra BP, Naveen BK (2014) Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro. Drug Dev Ind Pharm 40:1371–1377
Challa VR, Ravindra BP, Challa SR, Johnson B, Maheswari C (2013) Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models. Drug Dev Ind Pharm 39:865–872
Pingili RB, Pawar AK, Challa SR (2015) Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity. Drug Dev Ind Pharm 41:1793–1800
Pingili RB, Vemulapalli S, Dirisala VR, Mullapudi SS, Gullapalli Y, Kilaru NB (2021) Effect of naringenin on the pharmacokinetics of metoprolol succinate in rats. Xenobiotica 51:926–932
Vemulapalli S (2016) Influence of pomegranate juice on the CYP3A4-mediated metabolism and p-glycoprotein mediated transport of saquinavir in vivo and ex vivo models. Indones J Pharm 27:152
Ahn CY, Bae SK, Jung YS, Lee I, Kim YC, Lee MG, Shin WG (2008) Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus. Drug Metab Dispos 36:1233–1241
Wan J, Shoaf SE, Ernstgard E, Song BJ (2006) Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats. J Pharm Pharmacol 58:51–61
Mahli A, Koch A, Czech B, Peterburs P, Lechner A, Haunschild J, Müller M, Hellerbrand C (2015) Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats. Clin Phytosci 1:1–8
Zhang W, Hong R, Tian T (2013) Silymarin’s protective effects and possible mechanisms on alcoholic fatty liver for rats. Biomol Ther 21:264
Bui K, She F, Zhou D, Butler K, Al-Huniti N, Sostek M (2016) The effect of quinidine, a strong P-glycoprotein inhibitor, on the pharmacokinetics and central nervous system distribution of naloxegol. J Clin Pharmacol 56:497–505
Flores-Pérez C, Chávez-Pacheco JL, Ramírez-Mendiola B, Alemón-Medina R, García-Álvarez R, Juárez-Olguín H, Flores-Pérez J (2011) A reliable method of liquid chromatography for the quantification of acetaminophen and identification of its toxic metabolite N-acetyl-p-benzoquinoneimine for application in pediatric studies. Biomed Chromatogr 25:760–766
Powis G, Svingen BA, Dahlin DC, Nelson SD (1984) Enzymatic and non-enzymatic reduction of N-acetyl-p-benzoquinone imine and some properties of the N-acetyl-p-benzosemiquinone imine radical. Biochem Pharmacol 33:2367–2370
Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Férard G, Franck PF, Gella FJ, Hoelzel W, Jørgensen PJ, Kanno T, Kessne A, Klauker R, Kristiansen N, Lessinger JM, Linsinger TP, Misaki H, Panteghini M, Pauwels J, Schimmel HG, Vialle A, Weidemann G, Siekmann L (2002) IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase. Clin Chem Lab Med 40:635–642
Young DS, Pestaner L, Gibberman V (1975) Effects of drugs on clinical laboratory tests. Clin Chem 21:1D-432D
Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177:751–766
Bablok W, Passing H, Bender R, Schneider B (1988) A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, part III. J Clin Chem Clin Biochem 26:783–790
Sobeh M, Esmat A, Petruk G, Abdelfattah MAO, Dmirieh M, Monti DM, Abdel-Naim AB, Wink M (2018) Phenolic compounds from Syzygium jambos (Myrtaceae) exhibit distinct antioxidant and hepatoprotective activities in vivo. J Funct Foods 41:223–231
Wang PY, Kaneko T, Wang Y, Sato A (1999) Acarbose alone or in combination with ethanol potentiates the hepatotoxicity of carbon tetrachloride and acetaminophen in rats. Hepatology 29:161–165
Bailey DN (1997) Relative binding of acetaminophen, lidocaine, phenobarbital, phenytoin, quinidine, and theophylline to human tissues in vitro. J Anal Toxicol 21:1–4
Pond SM, Tong TG, Kaysen GA, Menke DJ, Galinsky RE, Roberts SM, Levy G (1982) Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophen. J Toxicol Clin Toxicol 19:1–16
Smith JA, Hine ID, Beck P, Routledge PA (1986) Paracetamol toxicity: is enzyme induction important? Hum Toxicol 5:383–385
Sansone-Parsons A, Krishna G, Simon J, Soni P, Kantesaria B, Herron J, Stoltz R (2007) Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers. Antimicrob Agents Chemother 51:495–502
Guengerich FP (2021) A history of the roles of cytochrome P450 enzymes in the toxicity of drugs. Toxicol Res 37:1–23
Florén CH, Thesleff P, Nilsson A (1987) Severe liver damage caused by therapeutic doses of acetaminophen. Acta Med Scand 222:285–288
Thummel KE, Slattery JT, Nelson SD, Lee CA, Pearson PG (1989) Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes. Toxicol Appl Pharmacol 100:391–397
Whitcomb DC, Block GD (1994) Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 272:1845–1850
Zimmerman HJ, Maddrey WC (1995) Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 22:767–773
Brackett CC, Bloch JD (2000) Phenytoin as a possible cause of acetaminophen hepatotoxicity: case report and review of the literature. Pharmacotherapy 20:229–233
O’Shea D, Kim RB, Wilkinson GR (1997) Modulation of CYP2EI activity by isoniazid in rapid and slow N-acetylators. Br J Clin Pharmacol 43:99–103
Paracetamol interaction, reactions weekly, 2001;853:10.
Henderson NC, Pollock KJ, Frew J, Mackinnon AC, Flavell RA, Davis RJ, Sethi T, Simpson KJ (2007) Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 56:982–990
Schmidt LE, Dalhoff K (2003) The impact of current tobacco use on the outcome of paracetamol poisoning. Aliment Pharmacol Ther 18:979–985